Modular bioreactors are being developed to slash vaccine production times by six months
Innovative modular bioreactors are being designed to revolutionize vaccine manufacturing, potentially cutting production timelines by six months to ensure rapid medical responses during global health crises.
The shift toward modular bioreactors is a cornerstone of new strategies to secure health sovereignty and prevent medicine shortages. These flexible platforms allow for the rapid scaling of mRNA technology, with the potential to produce billions of doses annually.
There's more to this story — open the app to keep reading.
Continue Reading in App
1 more paragraphs · plus a 3-question quiz